Clinical trial enrollment of adolescents and young adults with sarcoma

Lara Davis, Katherine A. Janeway, Aaron R. Weiss, Yen Lin E. Chen, Thomas J. Scharschmidt, Mark Krailo, Julia L. Glade Bender, Lisa M. Kopp, Shreyaskumar R. Patel, Gary K. Schwartz, L. Elise Horvath, Douglas S. Hawkins, Meredith K. Chuk, Denise K. Reinke, Richard G. Gorlick, R. Lor Randall

Research output: Contribution to journal › Comment/debate

14 Citations (Scopus)

Abstract

More than half of all sarcomas occur in adolescents and young adults (AYAs) aged 15 to 39 years. After the publication of the AYA series in the April 1, 2016 issue of Cancer, several leaders in the field of sarcoma across disciplines gathered to discuss the status of sarcoma clinical research in AYAs. They determined that a focused effort to include the underrepresented and understudied AYA population in current and future sarcoma clinical trials is overdue. Trial enrichment for AYA-aged sarcoma patients will produce more meaningful results that better represent the disease's biology, epidemiology, and treatment environment. To address the current deficit, this commentary outlines changes believed to be necessary to expediently achieve an increase in the enrollment of AYAs in sarcoma clinical trials. Cancer 2017;123:3434-40.

Original languageEnglish (US)
Pages (from-to)3434-3440
Number of pages7
JournalCancer
Volume123
Issue number18
DOIs
StatePublished - Sep 15 2017

Fingerprint

Sarcoma
Young Adult
Clinical Trials
Publications
Neoplasms
Epidemiology
Research
Population

Keywords

  • adolescent
  • clinical trials
  • National Clinical Trials Network
  • sarcoma
  • young adult

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Davis, L., Janeway, K. A., Weiss, A. R., Chen, Y. L. E., Scharschmidt, T. J., Krailo, M., ... Randall, R. L. (2017). Clinical trial enrollment of adolescents and young adults with sarcoma. Cancer, 123(18), 3434-3440. https://doi.org/10.1002/cncr.30757

Clinical trial enrollment of adolescents and young adults with sarcoma. / Davis, Lara; Janeway, Katherine A.; Weiss, Aaron R.; Chen, Yen Lin E.; Scharschmidt, Thomas J.; Krailo, Mark; Glade Bender, Julia L.; Kopp, Lisa M.; Patel, Shreyaskumar R.; Schwartz, Gary K.; Horvath, L. Elise; Hawkins, Douglas S.; Chuk, Meredith K.; Reinke, Denise K.; Gorlick, Richard G.; Randall, R. Lor.

In: Cancer, Vol. 123, No. 18, 15.09.2017, p. 3434-3440.

Research output: Contribution to journal › Comment/debate

Davis, L, Janeway, KA, Weiss, AR, Chen, YLE, Scharschmidt, TJ, Krailo, M, Glade Bender, JL, Kopp, LM, Patel, SR, Schwartz, GK, Horvath, LE, Hawkins, DS, Chuk, MK, Reinke, DK, Gorlick, RG & Randall, RL 2017, 'Clinical trial enrollment of adolescents and young adults with sarcoma', Cancer, vol. 123, no. 18, pp. 3434-3440. https://doi.org/10.1002/cncr.30757
Davis L, Janeway KA, Weiss AR, Chen YLE, Scharschmidt TJ, Krailo M et al. Clinical trial enrollment of adolescents and young adults with sarcoma. Cancer. 2017 Sep 15;123(18):3434-3440. https://doi.org/10.1002/cncr.30757
Davis, Lara ; Janeway, Katherine A. ; Weiss, Aaron R. ; Chen, Yen Lin E. ; Scharschmidt, Thomas J. ; Krailo, Mark ; Glade Bender, Julia L. ; Kopp, Lisa M. ; Patel, Shreyaskumar R. ; Schwartz, Gary K. ; Horvath, L. Elise ; Hawkins, Douglas S. ; Chuk, Meredith K. ; Reinke, Denise K. ; Gorlick, Richard G. ; Randall, R. Lor. / Clinical trial enrollment of adolescents and young adults with sarcoma. In: Cancer. 2017 ; Vol. 123, No. 18. pp. 3434-3440.
@article{c8f945e607f544e1a2a94623771ea056,
title = "Clinical trial enrollment of adolescents and young adults with sarcoma",
abstract = "More than half of all sarcomas occur in adolescents and young adults (AYAs) aged 15 to 39 years. After the publication of the AYA series in the April 1, 2016 issue of Cancer, several leaders in the field of sarcoma across disciplines gathered to discuss the status of sarcoma clinical research in AYAs. They determined that a focused effort to include the underrepresented and understudied AYA population in current and future sarcoma clinical trials is overdue. Trial enrichment for AYA-aged sarcoma patients will produce more meaningful results that better represent the disease's biology, epidemiology, and treatment environment. To address the current deficit, this commentary outlines changes believed to be necessary to expediently achieve an increase in the enrollment of AYAs in sarcoma clinical trials. Cancer 2017;123:3434-40.",
keywords = "adolescent, clinical trials, National Clinical Trials Network, sarcoma, young adult",
author = "Lara Davis and Janeway, {Katherine A.} and Weiss, {Aaron R.} and Chen, {Yen Lin E.} and Scharschmidt, {Thomas J.} and Mark Krailo and {Glade Bender}, {Julia L.} and Kopp, {Lisa M.} and Patel, {Shreyaskumar R.} and Schwartz, {Gary K.} and Horvath, {L. Elise} and Hawkins, {Douglas S.} and Chuk, {Meredith K.} and Reinke, {Denise K.} and Gorlick, {Richard G.} and Randall, {R. Lor}",
year = "2017",
month = "9",
day = "15",
doi = "10.1002/cncr.30757",
language = "English (US)",
volume = "123",
pages = "3434--3440",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "18",

}

TY - JOUR

T1 - Clinical trial enrollment of adolescents and young adults with sarcoma

AU - Davis, Lara

AU - Janeway, Katherine A.

AU - Weiss, Aaron R.

AU - Chen, Yen Lin E.

AU - Scharschmidt, Thomas J.

AU - Krailo, Mark

AU - Glade Bender, Julia L.

AU - Kopp, Lisa M.

AU - Patel, Shreyaskumar R.

AU - Schwartz, Gary K.

AU - Horvath, L. Elise

AU - Hawkins, Douglas S.

AU - Chuk, Meredith K.

AU - Reinke, Denise K.

AU - Gorlick, Richard G.

AU - Randall, R. Lor

PY - 2017/9/15

Y1 - 2017/9/15

N2 - More than half of all sarcomas occur in adolescents and young adults (AYAs) aged 15 to 39 years. After the publication of the AYA series in the April 1, 2016 issue of Cancer, several leaders in the field of sarcoma across disciplines gathered to discuss the status of sarcoma clinical research in AYAs. They determined that a focused effort to include the underrepresented and understudied AYA population in current and future sarcoma clinical trials is overdue. Trial enrichment for AYA-aged sarcoma patients will produce more meaningful results that better represent the disease's biology, epidemiology, and treatment environment. To address the current deficit, this commentary outlines changes believed to be necessary to expediently achieve an increase in the enrollment of AYAs in sarcoma clinical trials. Cancer 2017;123:3434-40.

AB - More than half of all sarcomas occur in adolescents and young adults (AYAs) aged 15 to 39 years. After the publication of the AYA series in the April 1, 2016 issue of Cancer, several leaders in the field of sarcoma across disciplines gathered to discuss the status of sarcoma clinical research in AYAs. They determined that a focused effort to include the underrepresented and understudied AYA population in current and future sarcoma clinical trials is overdue. Trial enrichment for AYA-aged sarcoma patients will produce more meaningful results that better represent the disease's biology, epidemiology, and treatment environment. To address the current deficit, this commentary outlines changes believed to be necessary to expediently achieve an increase in the enrollment of AYAs in sarcoma clinical trials. Cancer 2017;123:3434-40.

KW - adolescent

KW - clinical trials

KW - National Clinical Trials Network

KW - sarcoma

KW - young adult

UR - http://www.scopus.com/inward/record.url?scp=85028979707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028979707&partnerID=8YFLogxK

U2 - 10.1002/cncr.30757

DO - 10.1002/cncr.30757

M3 - Comment/debate

C2 - 28493547

AN - SCOPUS:85028979707

VL - 123

SP - 3434

EP - 3440

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 18

ER -

Access to Document